These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18257051)

  • 1. Hyperhemolysis syndrome: a relative contraindication for transfusion.
    Lu RP; Clark P; Mintz PD
    J Hosp Med; 2008 Jan; 3(1):78-80. PubMed ID: 18257051
    [No Abstract]   [Full Text] [Related]  

  • 2. Red blood cell alloimmunization: lessons from sickle cell disease.
    Treml A; King KE
    Transfusion; 2013 Apr; 53(4):692-5. PubMed ID: 23565994
    [No Abstract]   [Full Text] [Related]  

  • 3. Red blood cell alloimmunization in sickle cell disease-prevalence and trends: a single-center cross-sectional study from United Kingdom.
    Mijovic A; Perera IG; Thein SL
    Transfusion; 2013 Dec; 53(12):3279-80. PubMed ID: 24320815
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
    Uhlmann EJ; Shenoy S; Goodnough LT
    Transfusion; 2014 Feb; 54(2):384-8. PubMed ID: 23692505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
    Chonat S; Arthur CM; Zerra PE; Maier CL; Jajosky RP; Yee MEM; Miller MJ; Josephson CD; Roback JD; Fasano R; Stowell SR
    Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells.
    Vichinsky EP
    Immunohematology; 2012; 28(1):20-3. PubMed ID: 22646146
    [No Abstract]   [Full Text] [Related]  

  • 7. Sickle cell disease: a review.
    Roseff SD
    Immunohematology; 2009; 25(2):67-74. PubMed ID: 19927623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion protocol for patients with sickle hemoglobinopathies at Children's National Medical Center.
    Fasano RM; Paul W; Siegal E; Luban NL
    Immunohematology; 2012; 28(1):13-6. PubMed ID: 22646144
    [No Abstract]   [Full Text] [Related]  

  • 9. Allosensitization in patients receiving multiple blood transfusions.
    Sakhalkar VS; Roberts K; Hawthorne LM; McCaskill DM; Veillon DM; Caldito GC; Cotelingam JD
    Ann N Y Acad Sci; 2005; 1054():495-9. PubMed ID: 16339705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.
    Ameen R; Al Shemmari S; Al-Bashir A
    Transfusion; 2009 Aug; 49(8):1649-54. PubMed ID: 19453992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case reports: delayed hemolytic transfusion reaction in sickle cell disease.
    Syed SK; Sears DA; Werch JB; Udden MM; Milam JD
    Am J Med Sci; 1996 Oct; 312(4):175-81. PubMed ID: 8853066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion practices for patients with sickle cell disease at major academic medical centers participating in the Atlanta Sickle Cell Consortium.
    Winkler AM; Josephson CD
    Immunohematology; 2012; 28(1):24-6. PubMed ID: 22646147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of hemoglobin electrophoresis to distinguish between severe delayed hemolytic transfusion reaction versus hyperhemolysis syndrome.
    Lukin R; Law JY; Lokhandwala PM
    Transfus Apher Sci; 2024 Jun; 63(3):103919. PubMed ID: 38582651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected Anemia and Reticulocytopenia in an Adolescent With Sickle Cell Anemia Receiving Chronic Transfusion Therapy.
    Blauel ER; Grossmann LT; Vissa M; Miller ST
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):e438-40. PubMed ID: 26207780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute haemolytic reaction due to anti-Wb: a case report.
    Wright T; Brown P; Marais I; Hong FS
    Vox Sang; 2013 Nov; 105(4):355-7. PubMed ID: 23679095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
    Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab.
    Fuja C; Kothary V; Carll TC; Singh S; Mansfield P; Wool GD
    Transfusion; 2022 Jul; 62(7):1446-1451. PubMed ID: 35588309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.
    Venkateswaran L; Teruya J; Bustillos C; Mahoney D; Mueller BU
    Pediatr Blood Cancer; 2011 Aug; 57(2):294-6. PubMed ID: 21298771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell transfusion in a patient with anti-AnWj: a case report.
    Stowers RE; Richa EM; Stubbs JR; Moore SB
    Immunohematology; 2007; 23(2):55-8. PubMed ID: 18004934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. For the patient. Alloimmunization: one risk of treating sickle cell disease.
    Ethn Dis; 2010; 20(2):195. PubMed ID: 20506598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.